Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New MRI method could speed up bladder cancer diagnosis

NCT ID NCT05779631

Diagnosis Sponsor: Radboud University Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares a new diagnostic approach—using an MRI plus a same-day biopsy—against the standard procedure (TURBT) for diagnosing muscle-invasive bladder cancer. Researchers will enroll 360 adults suspected of having this aggressive cancer. The goal is to see if the new method leads to faster treatment and better outcomes, such as longer survival without the cancer spreading.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
mpMRI plus same-day cystoscopic bladder biopsy
What this could lead to
If successful, this could replace the standard two-step diagnosis with a faster, single-day procedure, potentially improving survival by starting treatment sooner.
What could go wrong
This is a diagnostic study, not a treatment trial. The MRI approach may not prove more effective than current methods, and some patients may still need additional procedures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 360 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2023

Expected to finish

Jun 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients (18+ years of age) * Clinically suspected MIBC * No lymph node or distant metastases * Written informed consent Exclusion Criteria: * Unable or unwilling to undergo mpMRI * Unfit for TURBT * Unfit for definitive treatment with curative intent * A history of cancer, including bladder cancer, except: non-melanoma skin cancer, prostate cancer on active surveillance or a solid malignant tumor ≥5 years disease-free since last treatment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bladder cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

infiltrating bladder urothelial carcinoma urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bladder cancer Muscle invasive bladder cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    19 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Amsterdam UMC, location AMC

    RECRUITING

    Amsterdam, Netherlands

  • Amsterdam UMC, location VUmc

    RECRUITING

    Amsterdam, Netherlands

  • Antoni van Leeuwenhoek - Netherlands Cancer Institute

    RECRUITING

    Amsterdam, Netherlands

  • Bernhoven ziekenhuis

    RECRUITING

    Uden, Netherlands

  • Canisius Wilhelmina Ziekenhuis

    RECRUITING

    Nijmegen, Netherlands

  • Erasmus Medical Center

    NOT_YET_RECRUITING

    Rotterdam, Netherlands

  • Jeroen Bosch ziekenhuis

    RECRUITING

    's-Hertogenbosch, Netherlands

  • Maasziekenhuis Pantein

    RECRUITING

    Boxmeer, Netherlands

  • Meander MC

    NOT_YET_RECRUITING

    Amersfoort, Netherlands

  • Medisch Spectrum Twente

    NOT_YET_RECRUITING

    Enschede, Netherlands

  • OLVG

    RECRUITING

    Amsterdam, Netherlands

  • Radboud university medical center

    RECRUITING

    Nijmegen, Netherlands

  • Rijnstate ziekenhuis

    RECRUITING

    Arnhem, Netherlands

  • St. Antonius ziekenhuis

    RECRUITING

    Nieuwegein, Netherlands

  • Treant

    NOT_YET_RECRUITING

    Emmen, Netherlands

  • University Medical Center Utrecht

    RECRUITING

    Utrecht, Netherlands

  • VieCuri medisch centrum

    RECRUITING

    Venlo, Netherlands

  • Ziekenhuis Gelderse Vallei

    RECRUITING

    Ede, Netherlands

  • Ziekenhuisgroep Twente

    RECRUITING

    Almelo, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.